ARCHIVES

Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

New Criteria For Comprehensive center Status finalized

November 17, 1989

Roswell Park Wins $1.3 Million In Stimulus Funding

June 19, 2009